Form 4: Lilly Endowment Inc. Sells 8,743 Shares of Eli Lilly & Co.

Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold 8,743 shares of common stock at a weighted average price of $740.059 per share.

Summary

• Lilly Endowment Inc. sold 8,743 shares of Eli Lilly & Co. common stock on February 8, 2024.
• The shares were sold at a weighted average price of $740.059 per share.
• The transactions occurred at prices ranging from $740.00 to $740.38 per share.
• Following the transaction, Lilly Endowment Inc. beneficially owns 99,325,067 shares of Eli Lilly & Co.

Sentiment

Score: 5

Explanation: The document is a neutral report of a share sale by a major shareholder. It doesn't indicate any positive or negative sentiment towards the company's performance or future prospects.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a major shareholder. Such filings are common and provide transparency into insider trading activity. The sale by Lilly Endowment Inc. is not necessarily indicative of a negative outlook on Eli Lilly & Co., but rather a portfolio management decision.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting insider transactions in publicly traded companies.
• The sale of shares by a major shareholder like Lilly Endowment Inc. is not uncommon and can be compared to similar transactions by other large institutional investors in the pharmaceutical industry.
• The volume of shares sold is relatively small compared to the total shares held by Lilly Endowment Inc., suggesting it is not a major divestment.

Stakeholder Impact

• The sale of shares by Lilly Endowment Inc. may have a minor impact on the share price of Eli Lilly & Co., but is unlikely to be significant given the relatively small volume of shares sold compared to the total outstanding shares.
• The transaction provides transparency to shareholders regarding insider activity.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, share sale, common stock, insider transaction, beneficial ownership